Unigen Pharmaceuticals, a US-based natural products R&D company, has established an office in Brussels. The company reportedly chose the location due to its history of supporting botanicals with nutritional functionality supported by science. Unigen plans offer its business model to markets in Central, Eastern and Western Europe. Unigen
"This move is but the first step of a major initiative in Europe by Unigen. We are intent on replicating our successes that we have had in Asia and North America. Unigen is committed to bringing patented, safe and efficacious ingredients, all discovered in natural products, to our strategic partners in Europe," said Doug Lynch, vice president of sales and marketing in a recent press release.
The new office will offer European customers direct technical, marketing, sales and regulatory assistance. Also, customers will have access to the company's library.